# Pulse Radiotherapy to Overcome Metastatic Immune System Evasion in Lung Cancer

> **NCT06622174** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Houda Bahig** · enrollment: 32 (estimated)

## Conditions studied

- Non Small Cell Lung Cancer
- Metastatic Lung Cancer

## Interventions

- **RADIATION:** Pulse radiotherapy

## Key facts

- **NCT ID:** NCT06622174
- **Lead sponsor:** Houda Bahig
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-04
- **Primary completion:** 2027-04
- **Final completion:** 2027-08
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2024-10-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06622174

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06622174, "Pulse Radiotherapy to Overcome Metastatic Immune System Evasion in Lung Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06622174. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*